Cannabis Pharmaceuticals Market

Report Highlights

The report broadly covers different brand of cannabis based on their compound type. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for cannabis pharmaceuticals market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each brand, compound type, distribution channel, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional cannabis pharmaceuticals markets; it explains the major market drivers of the global cannabis pharmaceuticals industry, current trends within the industry, major applications, and the regional dynamics of the global cannabis pharmaceuticals market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global cannabis pharmaceuticals market.

Report Includes

• 37 tables and 45 figures
• An up-to-date analysis of the Global Cannabis Pharmaceuticals Market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for Global Cannabis Pharmaceuticals Market, and corresponding market share analysis by brand, compound type, distribution channel, and region.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Cannabis Pharmaceuticals, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Cannabis Pharmaceuticals Market as compared to overall global economy.
• Insight into the growth development strategies of major Cannabis Pharmaceuticals manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including GW Pharmaceuticals, plc, AbbVie Inc., Insys Therapeutics, Inc., Corbus Pharmaceuticals Holdings Inc., Teva Pharmaceutical Industries Ltd., Avicanna Inc., Solvay S.A., Cannabis Pharmaceuticals Inc., and others.

Summary

Cannabis commonly known as marijuana refers to a cluster of three plants with psychotropic properties, namely Cannabis sativa, Cannabis ruderalis, and Cannabis indica. Cannabis is quite safe and has lesser side effects when compared to other treatment methods.

Cannabis is effectively used to treat symptoms such as, reducing nausea, vomiting, and many other conditions. The emergence of Cannabis 3.0 has effectively highlighted the requirement of value-based outcomes instead of perception-based outcomes. In this method, there is a sift of the usage of tradition method of smoking the whole cannabis flower to the uptake of the processed, and packaged cannabis derived products.